Brief: Daewoong Pharma Says Wins 385 Billion Won Drug Export Order From Chinese Firm
17/03/2021 22:49
March 18 (Reuters) -
* DAEWOONG PHARMA: WINS 385 BILLION WON ORDER FROM CHINESE
FIRM TO
EXPORT FEXUPRAZAN
Further company coverage: 069620.KS
(Reporting by Joyce Lee)
((JungYoon.Lee@thomsonreuters.com;))
Recent news on Daewoong Pharma
See all newsBrief: Daewoong Pharma Q2 Operating. Profit 77 Billion Won, Up 23% Y/Y
Brief: Daewoong Pharma Wins 92.6 Billion Won Order
Brief: Daewoong Pharma Q4 Operating Profit 45.5 Billion Won, Up 9% From Year Earlier
Brief: Daewoong Pharma Q2 Operating Profit 62.5 Billion Won, Up 26% From Year Earlier
Brief: Daewoong Pharma Q1 Operating Profit 42 Billion Won, Up 34.5% From Year Earlier